GGrantIndex
← Leaderboards

Eleonora Grandi

University Of California At Davis

$9,868,010
Attributed
$14,893,958
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,893,958 · 9

By mechanism

R01$7,261,958 · 3
OT2$5,716,980 · 1
P01$1,835,020 · 2
R13$80,000 · 3

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Arrhythmia

Research focus

ArrhythmiaHeart DiseasesTissuesCellsCardiacExperimental StudyElectrophysiology (Science)LinkHeart FailureIon ChannelSignal TransductionComplexMuscle CellsFunctional DisorderEventInsightMolecularComputer ModelsSimulationAffectPhysiologicalDesignCardiac MyocytesPharmacotherapy

Grant awards (27)

Multiomics and Functional Characterization Establish Druggable Targets for PVC-Driven Idiopathic VF$777,300
R01 · FY2025 · HL
Sex-specific arrhythmogenic mechanisms of atrial fibrillation$634,892
R01 · FY2025 · HL · contact PI
Calcium Driven Fibroblast Dysregulation in Human Atrial Profibrotic Remodeling$570,537
R01 · FY2025 · HL · contact PI
Multiomics and Functional Characterization Establish Druggable Targets for PVC-Driven Idiopathic VF$749,641
R01 · FY2024 · HL
Quantifying the role of myocyte ultrastructure in atrial health and disease$418,560
R01 · FY2024 · HL · contact PI
Systems Approach to Understanding Cardiovascular Disease - Ion channels, Ca2+ regulation and signaling$20,000
R13 · FY2024 · HL · contact PI
Multiomics and Functional Characterization Establish Druggable Targets for PVC-Driven Idiopathic VF$790,649
R01 · FY2023 · HL
Quantifying the role of myocyte ultrastructure in atrial health and disease$427,102
R01 · FY2023 · HL · contact PI
Core (Grandi)$386,560
P01 · FY2023 · HL · contact PI
Quantifying the role of myocyte ultrastructure in atrial health and disease$440,828
R01 · FY2022 · HL · contact PI
Core (Grandi)$386,560
P01 · FY2022 · HL · contact PI
Systems Approach to Understanding Cardiovascular Disease and Arrhythmias - Cell diversity in the cardiovascular system, cell-autonomous and cell-cell signaling$30,000
R13 · FY2022 · HL · contact PI
Development of the Predictive NeuroCardiovascular Simulator$1,498,542
OT2 · FY2021 · OD
Quantifying the role of myocyte ultrastructure in atrial health and disease$469,027
R01 · FY2021 · HL · contact PI
Core (Grandi)$386,560
P01 · FY2021 · HL · contact PI
Development of the Predictive NeuroCardiovascular Simulator$1,450,692
OT2 · FY2020 · OD
Development of the Predictive NeuroCardiovascular Simulator$691,874
OT2 · FY2020 · OD
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation$393,854
R01 · FY2020 · HL · contact PI
Core (Grandi)$386,560
P01 · FY2020 · HL · contact PI
Development of the Predictive NeuroCardiovascular Simulator$691,875
OT2 · FY2019 · OD
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation$393,854
R01 · FY2019 · HL · contact PI
Core (Grandi)$288,780
P01 · FY2019 · HL · contact PI
Development of the Predictive NeuroCardiovascular Simulator$1,383,997
OT2 · FY2018 · OD
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation$393,854
R01 · FY2018 · HL · contact PI
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation$393,854
R01 · FY2017 · HL · contact PI
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation$408,006
R01 · FY2016 · HL · contact PI
Systems Approach to understanding Excitation-Coupling and Cardiac Arrhythmias$30,000
R13 · FY2016 · HL